Coagulation Modifier Agents
Lilley Pharmacology Text: Chapter 26

Original Text modified by:
Anita A. Kovalsky, R.N., M.N.Ed.
Professor of Nursing

Original PPT by:
Professor Pat Woodbery, ARNP
Professor of Nursing

What is Hemostasis?????

In other words……..

What Upsets the Balance
between Thrombogenesis and
Thrombolysis???

Atherosclerosis

Immobility (particularly after surgery)

Dysrhythmias (Atrial Fibrillation)

Artificial Heart Valves

These clients require prophylactic anticoagulation or……


A Thromboembolic Event May Occur…

Thrombophlebitis

Deep vein thrombosis (DVT)

Myocardial Infarction (MI)

Pulmonary Embolus (PE)

Cerebrovascular Accident (CVA)

 

Coagulation Modifiers: Categories and Agents
(Lilley pg. 410 Table 26-1)

Prototype Anticoagulants
(Trade name in parentheses)
(Lilley pg. 415; Syllabus pg.41)

Heparin

(SQ or IV)

Half-life 1-2 hrs

Enoxaparin (Lovenox)

(SQ)

Half-life 4.5 hrs

Warfarin (Coumadin)

(PO)

Half-life 0.5-3 days

HEPARIN

Turns off 3 main activating factors:

II (thrombin)

IX

X

 

And to a lesser extent XI & XII

ENOXAPRIN (LOVENOX)
A low molecular weight heparin (LMWH) which is more predictable

More specific for turning off activating factors:

X

And to a lesser extent II (thrombin)

WARFARIN (COUMADIN)

More specific for turning off activating factors:

II

VII

IX

X

 

These factors rely heavily on Vitamin K for synthesis, so Warfarin works by interfering with proper production of Vitamin K

 

Lab Work for Therapeutic Regulation of Anticoagulant Medications (Cavenaugh pp. 49-52)

aPTT (1.5 –2.0 x control) = Heparin

(Activated Partial Thromboplastin Time)

INR (2.0-3.0 seconds for oral anticoagulation = Warfarin

(International Normalized Ratio)

PT (1.5-2.5 x control) = Warfarin

(Prothrombin Time)

Systemic Hemostatic Agents
(Lilley pg. 413; Syllabus pg.41)

NURSING ACTIONS FOR HEPARIN AND ORAL ANTICOAGULANTS
(Lilley pp. 426-427)

Rationale for drug

Correct dose

Site assessment

Check labs for therapeutic effects

Monitor for adverse effects

ANTICOAGULANT
PATIENT TEACHING
(Lilley pp. 414 & 430)

Increase risk of BLEEDING: avoid trauma

Periodic blood tests for Coumadin Therapy

Note OTC medications

Note diet

Prototype
Antiplatelet Agents
(Trade name in parentheses)
(Lilley pg. 419; Syllabus pg.41)

Acetylsalicylic Acid (Aspirin)

Clopidogrel (Plavix)

ANTIPLATELET
PATIENT TEACHING
(Lilley pg. 430)

Increase risk of BLEEDING: avoid trauma

ASA precautions

No ETOH or cigarette smoking

Note timing of antacids

Note diet

THE END